id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2025-P-7433-0005,FDA,FDA-2025-P-7433,"Interim Response from FDA CDER to University of Illinois, College of Pharmacy",Other,Response(s),2026-06-15T04:00:00Z,2026,6,2026-06-15T04:00:00Z,,2026-06-15T23:48:58Z,,0,0,09000064b93318f1
FDA-2025-P-7433-0004,FDA,FDA-2025-P-7433,Appendix II,Supporting & Related Material,Background Material,2026-01-02T05:00:00Z,2026,1,,,2026-01-02T19:49:37Z,,0,0,09000064b911412c
FDA-2025-P-7433-0003,FDA,FDA-2025-P-7433,Appendix I,Supporting & Related Material,Background Material,2026-01-02T05:00:00Z,2026,1,,,2026-01-02T19:49:34Z,,0,0,09000064b911412b
FDA-2025-P-7433-0001,FDA,FDA-2025-P-7433,Citizen Petition from Sarfaraz Niazi,Other,Citizen Petition,2026-01-02T05:00:00Z,2026,1,2026-01-02T05:00:00Z,,2026-01-02T19:49:16Z,,1,0,09000064b9113ae0
FDA-2025-P-7433-0002,FDA,FDA-2025-P-7433,Acknowledgement Letter from FDA DMB to Sarfaraz Niazi,Other,Acknowledgement Letter/Receipt,2026-01-02T05:00:00Z,2026,1,2026-01-02T05:00:00Z,,2026-01-02T19:49:21Z,,0,0,09000064b9113ae3